JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB267021

Human SECTM1 knockout A549 cell line

Human SECTM1 knockout A549 cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SECTM1 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 17 bp deletion in exon 2 and 20 bp deletion in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

別名を表示する

K12, K12 protein, Protein K-12, SCTM1_HUMAN, Secreted and transmembrane 1, Secreted and transmembrane protein 1, Type 1a transmembrane protein

2 Images
Sanger Sequencing - Human SECTM1 knockout A549 cell line (AB267021)
  • Sanger seq

Unknown

Sanger Sequencing - Human SECTM1 knockout A549 cell line (AB267021)

Allele-2 : 17 bp deletion in exon 2.

Sanger Sequencing - Human SECTM1 knockout A549 cell line (AB267021)
  • Sanger seq

Unknown

Sanger Sequencing - Human SECTM1 knockout A549 cell line (AB267021)

Allele-1 : 20 bp deletion in exon2

Key facts

細胞タイプ

A549

生物種

Human

組織

Lung

製品の状態

Liquid

form

ノックアウト検証方法

Sanger Sequencing

ノックアウト変異

Knockout achieved by using CRISPR/Cas9, 17 bp deletion in exon 2 and 20 bp deletion in exon 2

疾病

Carcinoma

製品の詳細

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

製品内容

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab267021-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255450 Human wild-type A549 cell line", "number":"AB267021-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab267021 Human SECTM1 knockout A549 cell line", "number":"AB267021-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab267021-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255450 Human wild-type A549 cell line", "number":"AB267021-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab267021 Human SECTM1 knockout A549 cell line", "number":"AB267021-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267021-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267021 Human SECTM1 knockout A549 cell line", "number":"AB267021-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267021-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267021 Human SECTM1 knockout A549 cell line", "number":"AB267021-CMP01", "productcode":"" } ] } } }

出荷温度及び保存条件

遺伝子名
SECTM1
遺伝子編集のタイプ
Knockout
遺伝子編集の方法
CRISPR technology
ノックアウト検証方法
Sanger Sequencing
出荷温度
Dry Ice
短期保存温度
-196°C
長期保存温度
-196°C

取り扱い方法

初回取り扱いガイドライン

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

継代培養ガイドライン
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
  • Do not allow the cell density to exceed 7x104 cells/cm2.
培養培地

F-12K + 10% FBS

凍結保存培地

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

SECTM1 also known as Secreted and Transmembrane 1 and sometimes as K12 is a protein with a molecular mass of approximately 28 kDa. It expresses both membrane-bound and soluble forms found mainly in epithelial cells and in some types of immune cells such as monocytes. SECTM1 resides in the Golgi apparatus and can be secreted outside the cell indicating its role in cell signaling and communication.
Biological function summary

The protein plays a role in modulating immune responses. SECTM1 interacts with CD7 a cell surface glycoprotein found on T cells and natural killer cells influencing their activation and proliferation. This interaction is important for immune system regulation and SECTM1 can function together with other immune-related proteins but usually operates independently rather than as part of a larger protein complex.

Pathways

SECTM1 is involved in immunological pathways particularly those governing T-cell activation and the broader inflammatory response. Within these pathways SECTM1 connects with proteins like CD7 and is associated with the PI3K/Akt signaling cascade. This linkage influences cell survival and growth bridging innate and adaptive immunity.

SECTM1 has associations with several inflammatory and autoimmune conditions as well as cancer. Abnormal expression levels of SECTM1 have implications in disorders such as rheumatoid arthritis where its interaction with CD7 appears to play a role in disease progression. Similarly in certain cancers altered SECTM1 expression leads to changes in immune cell behavior affecting tumor growth and metastasis.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

製品プロトコール

ターゲットの情報

See full target information SECTM1

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com